Vistagen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vistagen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vistagen Today - Breaking & Trending Today

Vistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue

SOUTH SAN FRANCISCO, Calif., April 25, 2024 Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced positive results from a Phase 2A pilot study of PH15, an investigational pherine nasal spray, for improvement of psychomotor impairment caused by mental fatigue. PH15 demonstrated a statistically significant improvement in reaction time compared to placebo a ....

United States , Mexico City , Distrito Federal , Shawn Singh , Mark Mcpartland , Jose Maria Calvo , Caren Scannell , National Institute Of Psychiatry , Exchange Commission , Pherin Pharmaceuticals , Chief Executive Officer , National Institute , Sleep Disorders Clinic , Associate Professor , Principal Investigator , New Drug , Annual Report , Quarterly Report , Neurological Disorders , Sleep Deprivation , Mental Fatigue , Nasal Spray , Psychomotor Performance , Lreaction Time , Study Participants , Safety Profile ,

Vistagen Therapeutics Inc (VTGN) Reports Fiscal 2024 Q3 Results: A Closer Look at Financials ...

VTGN's Clinical Pipeline Advances as Q3 Financials Reflect Controlled R&D Spending ....

Shawn Singh , Development Expenses , Vistagen Therapeutics Inc , Administrative Expenses , Ash And Cash Equivalents , Product Candidates ,

Nasal Spray Fasedienol Provides Rapid Social Anxiety Benefit in Phase 3 Trial

Vistagen reported significant improvement of physician- and patient-reported anxiety among trial participants who underwent an anxiety-inducing public speaking exercise. ....

United States , Michaelr Liebowitz , Shawn Singh , Columbia University , York State Psychiatric Institute , Drug Administration , Subjective Units , Distress Scale , Liebowitz Social Anxiety Scale , Anxiety Disorders Clinic , New York State Psychiatric Institute , Clinical Global Impression , Global Impression , Social Anxiety Disorder ,

Vistagen Announces European Patent Office Intention to Grant New PH80 Nasal Spray Patent for the Treatment of Migraine

Vistagen , a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system disorders,. | June 13, 2023 ....

Trademark Office , European Patent Office , Vistagen Therapeutics , Nc Stock Exchange , Press Release , Ystem Vtgn Us92840h4002 ,

Vistagen Announces Stockholder-Approved Reverse Stock Split

Vistagen a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system disorders,. | June 6, 2023 ....

Computershare Trust Company , Company Board Of Directors , Exchange Commission On , Nasdaq Capital Market , Exchange Commission , Vistagen Therapeutics , Nc Stock Exchange , Press Release , Ystem Vtgn Us92840h2022 ,